Market Tracker

09/23 5:16pm ET

Sanofi SA (NYSE:SNY)

38.35
Delayed Data
As of Sep 23
 -0.22 / -0.57%
Today’s Change
37.41
Today|||52-Week Range
51.88
-10.08%
Year-to-Date
Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.
7:48am / MotleyFool.com - Paid Partner Content
Buffett Stock Wells Fargo Falls to 52-Week Low After Scandal
Sep 22 / GuruFocus News - Paid Partner Content
John Paulson Trims Synergy
Sep 23 / GuruFocus News - Paid Partner Content
Wells Fargo One of Only Two Buffett Stocks at 52-Week Low Price After Scandal
Sep 21 / GuruFocus News - Paid Partner Content
European Markets Rally Following Fed Decision; Oil Price Increase
Sep 22 / TheStreet.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Buffett Stock Wells Fargo Falls Close to 52-Week Low Post Scandal
Sep 22 / GuruFocus News - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
New Setback for Sanofi's Lantus Increases Need for M&A
Sep 22 / TheStreet.com - Paid Partner Content
Sanofi in a State of Suspended Animation Until Boehringer Ingelheim Swap
Sep 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close38.57
Today’s open38.30
Day’s range38.28 - 38.54
Volume1,086,862
Average volume (3 months)2,244,924
Market cap$98.7B
Dividend yield4.34%
Data as of 4:02pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-14.57%
P/E ratio24.2
Price/Sales2.96
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.51+0.21%
BMYBristol-Myers Squibb+0.06+0.11%
ABBVAbbVie-0.10-0.15%
GSKGlaxoSmithKline-0.16-0.37%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateOctober 29, 2016
EPS forecast (this quarter)$0.87
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts